Skip to main content

Validation of the Brandwein Gensler Risk Model in Patients of Oral Cavity Squamous Cell Carcinoma in North India

Abstract

India has one of the highest incidences of oral squamous cell carcinoma (OSCC), with 75,000–80,000 new cases a year. The outcome in early oral cancer is better, but a significant proportion (12–14%) of these patients still relapses and dies due to locoregional or distant recurrences. Several clinicopathological and molecular factors have been used to prognosticate and predict outcomes in these patients of OSCC. The present study aims to validate Brandwein Gensler (BG) risk predictive model in surgically treated OSCC patients in a tertiary care centre in North India. All oral cavity cancer patients, treated in the Department of Surgical Oncology, King George’s Medical University, between 2013 and 2017, were reviewed. Patients with histologically diagnosed OSCC, aged > 18 years undergoing primary surgical resection were included in the study. The final histopathological evaluation was done by a dedicated pathologist to categorize patients according to BG model risk categories. This model comprises of three factors, lymphocytic host response, perineural invasion and worst pattern of invasion, scored by the method described by Brandwein Gensler et al. The sum of these scores is used to define low, moderate and high risk categories. The study, conducted during 2013–2017, included 149 patients. Median age was 45 years (range 25–75 years). Tobacco use was noted in 143 patients. Buccal mucosa was the most common site (51%). Surgical margins were clear (> 5 mm) in 97.9% cases. Postoperative radiotherapy was given in 47.7% patients. Locoregional recurrences (LRR) (primary site and neck) were documented in 17 of the 149 patients (11.4%). There was no synchronous or metachronous distant metastasis noted in any of the study patients. Six patients had disease specific mortality. Among the 17 patients with LRR, majority (11) belonged to the high risk category of the BG risk model. Adjuvant radiotherapy had been administered in 10 of these 11 recurrent patients belonging to the high risk category. The Brandwein Gensler risk model is predictive of locoregional recurrences (p = 0.02) for OSCC undergoing primary surgery. It can be used to devise strategies to prevent recurrences or identification of recurrences at an earlier point for salvage. The benefit of further escalation of adjuvant therapy in the high risk category needs further studies, as 90% patients in this group recurred despite complete adjuvant treatment.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Dikshit R, et al. Cancer mortality in India: a nationally representative survey. Lancet. 2012;379(9828):1807–16.

    Article  PubMed  Google Scholar 

  2. B.W. Stewart, C.P. Wild, ed. World Cancer Report 2014 (International Agency for Research on Cancer, Lyon, 2014).

  3. Li Y, Bai S, Carroll W, Dayan D, et al. Validation of risk model: high risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2013;7:211–23.

    CAS  Article  PubMed  Google Scholar 

  4. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease free and overall survival. Am J Surg Pathol. 2005;29(2):167–78.

    Article  PubMed  Google Scholar 

  5. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):67–76.

    Article  PubMed  Google Scholar 

  6. Zevallos JP, Mazul AL, Walter V, Hayes DN. Gene expression subtype predicts nodal metastasis and survival in human papillomavirus-negative head and neck cancer. Laryngoscope. 2019;129:154–61. https://doi.org/10.1002/lary.27340.

    CAS  Article  PubMed  Google Scholar 

  7. Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histological risk model in a new patient cohort with primary head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34:676–88.

    Article  PubMed  Google Scholar 

  8. Vered M, Dayan D, Dobriyan A, et al. Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol. 2010;136:1039.

    Article  PubMed  Google Scholar 

  9. Jakobsson PA, Eneeroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Physiol. 1973;12:1–8.

    CAS  Article  Google Scholar 

  10. Bryne M, Boysen M, Alfsen CG, et al. The invasive front of carcinomas: the most important area for tumor prognosis. Anticancer Res. 1998;18:4757–64.

    CAS  PubMed  Google Scholar 

  11. Anneroth G, Batsakis J, Luna M. Review of the literature and recommended system of malignancy grading in oral squamous cell carcinoma. Scand J Dent Res. 1987;95:229–49.

    CAS  PubMed  Google Scholar 

  12. Lo WL, Ko S-Y, Chi LY, Wong YK, Chang RC-S. Outcomes of oral cancer in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61:751–8.

    Article  PubMed  Google Scholar 

  13. Gonzales-Moles MA, Esteban F, Rodriguez-Archilla A, Ruiz-Avila I, Gonzales-Moles S. Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol. 2002;38:394–7.

    Article  Google Scholar 

  14. Guerra MFM, Gias LN, Campo FR, Perez JS. Marginal and segmental mandibulectomy in patients with oral cancer: a statistical analysis of 106 cases. J Oral Maxillofac Surg. 2003;61:1289–96.

    Article  Google Scholar 

  15. Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED. Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol. 2003;39:130–7.

    CAS  Article  PubMed  Google Scholar 

  16. Jones HB, Sykes A, Bayman N, Sloan P, Swindell R, Patel M, Musgrove B. The impact of lymphovascular invasion on survival in oral carcinoma. Oral Oncol. 2009;45(1):10–5.

    CAS  Article  PubMed  Google Scholar 

  17. Liu SA, Wang CC, Jiang RS, Lee FY, Lin WJ, Lin JC. Pathological features and their prognostic impacts on oral cavity cancer patients among different sub sites—a single institute’s experience in Taiwan. Sci Rep. 2017;7:7451.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kavitha Jain.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Informed Consent

Informed valid consent obtained from patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chaturvedi, A., Husain, N., Misra, S. et al. Validation of the Brandwein Gensler Risk Model in Patients of Oral Cavity Squamous Cell Carcinoma in North India. Head and Neck Pathol 14, 616–622 (2020). https://doi.org/10.1007/s12105-019-01082-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-019-01082-6

Keywords

  • Oral cavity cancer
  • Risk model
  • Surgery
  • Recurrence
  • Adjuvant